Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Bolt Biotherapeutics Inc. (BOLT) on Tuesday reported a loss of $15.2 million in its third quarter.

The Redwood City, California-based company said it had a loss of 40 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.

The company posted revenue of $1.1 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $1 million.

In the final minutes of trading on Tuesday, the company’s shares hit 64 cents. A year ago, they were trading at 98 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BOLT at https://www.zacks.com/ap/BOLT

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up